Top compounds associated with response to RLN3


Feature Type Standardized
Nominal ANOVA
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA YM-155 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA Docetaxel gCSI pan-cancer AAC -0.023 0.7
mRNA DMOG GDSC1000 pan-cancer AAC -0.014 0.7
mRNA tandutinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA gossypol CTRPv2 pan-cancer AAC -0.015 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC -0.02 0.7
Download CSV